Do you want to read an article? Please log in or register.
Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
Pulmonary Fibrosis
LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis
J Cyst Fibros
Vega-Hernandez G, MacGregor G, Wilfin A, Adams F, Haugh C, Baxter CA, Wöhling H, Clarke SL, Charman SC, Carr SB
doi: 10.1016/j.jcf.2025.04.012
RECOMMENDED
Further Publications
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Extension Study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Daines CL, Polineni D, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Quon BS, Ringshausen FC, Selvadurai H, Taylor-Cousar JL, Withers NJ, Sawicki GS, Lee T, Ahluwalia N, Morlando Geiger J, Jennings M, Tan YV, Waltz D, Ramsey B, Griese M, VX17-445-105 Study Group
doi: 10.1164/rccm.202411-2231OC
Pulmonary Fibrosis
Associations between income level and health outcomes in people with cystic fibrosis in Turkey
J Cyst Fibros
Metin Cakar N, Karabulut S, Yuksel Kalyoncu M, Selcuk Balcı M, Yıldız CA, Kocaman D, Uzunoglu B, Tastan G, Ergenekon AP, Erdem Eralp E, Gokdemir Y, Karakoc F, Karadag B
doi: 10.1016/j.jcf.2024.10.010
RECOMMENDED
Pulmonary Fibrosis
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Burgel PR, Sermet-Gaudelus I, Girodon E, Durieu I, Houdouin V, Audousset C, Macey J, Grenet D, Porzio M, Murris-Espin M, Reix P, Baravalle M, Belleguic C, Mely L, Verhille J, Weiss L, Reynaud-Gaubert M, Mittaine M, Hamidfar R, Ramel S, Cosson L, Douvry B, Danner-Boucher I, Foucaud P, Roy C, Burnet E, Raynal C, Audrezet MP, Da Silva J, Martin C, French Cystic Fibrosis Reference Network study group
doi: 10.1016/S2213-2600(24)00208-X
RECOMMENDED
Pulmonary Fibrosis
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, West NE, Kazmerski TM, Goralski JL, Flume PA, Roe AH, Hadjiliadis D, Uluer A, Mody S, Ladores S, Taylor-Cousar JL
doi: 10.1016/j.chest.2024.09.019
Pulmonary Hypertension
Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model
Adv Ther
Alsumali A, McLaughlin V, Chevure J, Klok R, Zhang W, Martinez EC, Pausch C, De Oliveira Pena J, van de Wetering G, Jootun M, Lautsch D, Hoeper MM
doi: 10.1007/s12325-025-03241-4
RECOMMENDED
Pulmonary Fibrosis
Clinical outcomes after liver transplant in people with cystic fibrosis: A systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros
Albaiz FA, Semenchuk J, Ma X, Lightfoot D, Gonska T, Tullis E, Stephenson AL
doi: 10.1016/j.jcf.2024.06.012
RECOMMENDED
Pulmonary Fibrosis
Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Caley LR, Gillgrass L, Zagoya C, Saumtally H, Duckstein F, H W, Mainz JG, Peckham DG
doi: 10.1016/j.jcf.2025.01.010
RECOMMENDED
Pulmonary Hypertension
Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Heart Lung Transplant
Chiu S, Bunclark K, Appenzeller P, Ghani H, Taboada D, Sheares K, Toshner M, Pepke-Zaba J, Cannon J, Taghavi F, Tsui S, Ng C, Jenkins DP
doi: 10.1016/j.healun.2024.09.005